Matthew Donley

Matthew Donley

Former Chief Operating OfficeratAurinia Pharmaceuticals· In proxies 2023–2025

Pay in FY2025-11% from the year before · Aurinia Pharmaceuticals stock +77.6% the same year

Matthew Donley was paid $2.2M in FY2025 (Dec), down 11%. Aurinia Pharmaceuticals stock rose 77.6% that year.

Pay$100 in the stock at the end of FY22 → $369
Pay is from the Summary Compensation Table of each Aurinia Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aurinia PharmaceuticalsPublic company · 3 yr
    • Former Chief Operating Officer2023 – Present · 3 yrStock in role +322%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?